YMC Europe GmbH

Articles by YMC Europe GmbH

Molnupiravir, which is a prodrug, and its active agent β-d-N4-hydroxycytidine can be separated by using a YMC-Triart C18 UHPLC column and a MS-compatible mobile phase.

Advances in Small Molecule Analysis: A Virtual Symposium

Wednesday and Thursday, June 29 and 30, 2022 Day 1: 8:00am – 11:15am EDT Day 2: 8:00am – 11:15am EDT Learn about the latest novel analytical techniques and workflows that help analysts obtain the results they are looking for in “real world” situations involving small molecules in the pharmaceutical sector and analysts analyzing small molecules in the environment.